The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France. Dimeglio C, Loubes JM, Deporte B, Dubois M, et al. J Infect 2020 Apr 29. pii: S0163-4453(20)30242.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dimeglio C, Loubes JM, Deporte B, Dubois M, et al. The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France. J Infect 2020 Apr 29. pii: S0163-4453(20)30242.
PMID: 32360497